BeOne Medicines Ltd. (ONC)
379.19
+7.21
(+1.94%)
USD |
NASDAQ |
Aug 25, 13:05
BeOne Medicines 1 Year Total Returns (Daily) : 18.59% for Aug. 24, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 24, 2026 | 18.59% |
| August 21, 2026 | 19.27% |
| August 20, 2026 | 19.34% |
| August 19, 2026 | 20.59% |
| August 18, 2026 | 15.60% |
| August 17, 2026 | 12.80% |
| August 14, 2026 | 12.20% |
| August 13, 2026 | 15.77% |
| August 12, 2026 | 24.63% |
| August 11, 2026 | 23.99% |
| August 10, 2026 | 24.57% |
| August 07, 2026 | 16.76% |
| August 06, 2026 | 10.48% |
| August 05, 2026 | 6.61% |
| August 04, 2026 | 6.15% |
| August 03, 2026 | 4.94% |
| July 31, 2026 | 4.94% |
| July 30, 2026 | 7.38% |
| July 29, 2026 | 7.02% |
| July 28, 2026 | 12.21% |
| July 27, 2026 | 11.81% |
| July 24, 2026 | 9.93% |
| July 23, 2026 | 10.83% |
| July 22, 2026 | 8.23% |
| July 21, 2026 | 9.16% |
| Date | Value |
|---|---|
| July 20, 2026 | 5.44% |
| July 17, 2026 | 7.46% |
| July 16, 2026 | 13.71% |
| July 15, 2026 | 15.41% |
| July 14, 2026 | 21.58% |
| July 13, 2026 | 21.44% |
| July 10, 2026 | 17.88% |
| July 09, 2026 | 18.44% |
| July 08, 2026 | 23.48% |
| July 07, 2026 | 28.20% |
| July 06, 2026 | 26.06% |
| July 02, 2026 | 21.83% |
| July 01, 2026 | 18.59% |
| June 30, 2026 | 17.72% |
| June 29, 2026 | 20.23% |
| June 26, 2026 | 9.98% |
| June 25, 2026 | 3.08% |
| June 24, 2026 | 3.87% |
| June 23, 2026 | 7.23% |
| June 22, 2026 | 10.00% |
| June 18, 2026 | 6.87% |
| June 17, 2026 | 3.38% |
| June 16, 2026 | -0.19% |
| June 15, 2026 | -0.53% |
| June 12, 2026 | -4.36% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| CRISPR Therapeutics AG | 5.07% |
| Basilea Pharmaceutica AG | 14.24% |
| Santhera Pharmaceuticals Holding AG | 26.36% |
| AC Immune SA | 33.02% |
| Idorsia Ltd. | 107.1% |